20170227-三星证券-Samsung_Healthcare_Weekly_16页_990kb

报告摘要

Sector Update Summary

Core Content

This document presents a detailed analysis of the global and Korean healthcare and pharmaceutical sector, including performance metrics, price-to-earnings (P/E) ratios, price-to-book (P/B) ratios, and market share data. The summary includes insights into various sub-sectors and companies within the healthcare and pharmaceutical industry.

Key Information

Analysts and Contact

Brian Lee - Team Head (Pharm/Biotech)
SunYoung Yoon - Analyst (Pharm/Biotech)
Kevin Kim - Analyst (Medical devices)
Wonyong Park - Research Associate

Indices Overview

The document provides performance data for several indices across different regions:

Korea

KRX Health Care: Forward P/E 34.6, portion of market cap 5.1%, 1-w performance 0.1%, 1-m performance 3.9%, 3-m performance 3.8%, ytd performance (2.5)%
Kospi Medical Supplies: Forward P/E 43.2, portion of market cap 2.3%, 1-w performance 2.5%, 1-m performance 7.4%, 3-m performance 8.8%, ytd performance 3.4%
Kosdaq Pharmaceuticals: Forward P/E 27.1, portion of market cap 2.2%, 1-w performance (0.7)%, 1-m performance 3.0%, 3-m performance 2.4%, ytd performance (4.4)%
Kosdaq Medical and Precision Machines: Forward P/E 16.9, portion of market cap 0.5%, 1-w performance (1.8)%, 1-m performance (2.5)%, 3-m performance (2.6)%, ytd performance (5.8)%

US

S&P 500 Healthcare: Forward P/E 16.0, portion of market cap 8.4%, 1-w performance 1.6%, 1-m performance 7.1%, 3-m performance 7.7%, ytd performance 8.3%
S&P 500 Pharma/Biotech: Forward P/E 15.3, portion of market cap 5.1%, 1-w performance 1.5%, 1-m performance 7.9%, 3-m performance 7.0%, ytd performance 7.3%
Nasdaq Biotechnology: Forward P/E 41.2, portion of market cap 2.4%, 1-w performance (1.0)%, 1-m performance 5.7%, 3-m performance 1.9%, ytd performance 9.4%
S&P 500 Healthcare equipment and services: Forward P/E 17.2, portion of market cap 3.3%, 1-w performance 1.7%, 1-m performance 5.8%, 3-m performance 8.9%, ytd performance 10.0%

Europe

MSCI Europe Healthcare: Forward P/E 16.1, portion of market cap 11.5%, 1-w performance 0.4%, 1-m performance 4.9%, 3-m performance 10.1%, ytd performance 4.9%
MSCI Europe Pharm/Bio: Forward P/E 15.6, portion of market cap 10.0%, 1-w performance 0.3%, 1-m performance 5.5%, 3-m performance 10.2%, ytd performance 5.4%
MSCI Europe Healthcare Equipment and Services: Forward P/E 21.4, portion of market cap 1.5%, 1-w performance 0.9%, 1-m performance 0.8%, 3-m performance 9.3%, ytd performance 1.1%

Japan

MSCI Japan Healthcare: Forward P/E 25.5, portion of market cap 7.2%, 1-w performance 0.8%, 1-m performance 2.5%, 3-m performance 3.8%, ytd performance 1.1%
MSCI Japan Pharm/Bio: Forward P/E 25.4, portion of market cap 5.3%, 1-w performance 0.8%, 1-m performance 4.0%, 3-m performance 4.7%, ytd performance 2.2%
Topix Pharma: Forward P/E 25.1, portion of market cap 4.8%, 1-w performance 0.8%, 1-m performance 4.0%, 3-m performance 5.0%, ytd performance 2.2%
MSCI Japan Healthcare Equipment and Services: Forward P/E 25.7, portion of market cap 1.9%, 1-w performance 1.0%, 1-m performance (1.2)%, 3-m performance (1.4)%, ytd performance (1.4)%

China

MSCI China Healthcare: Forward P/E 18.5, portion of market cap 1.6%, 1-w performance 1.6%, 1-m performance 5.7%, 3-m performance 8.9%, ytd performance 12.9%

India

MSCI India Healthcare: Forward P/E 24.8, portion of market cap 7.6%, 1-w performance 1.7%, 1-m performance 2.4%, 3-m performance (1.2)%, ytd performance 3.3%

Major Korean Healthcare Firms

Pharmaceutical Holdings

Hanmi Science: Market cap 3,961 KRWb, share price 63,600 KRW, 1-w performance 1.1%, 1-m performance 15.4%, 3-m performance (3.9)%, ytd performance (54.6)%
Green Cross Holdings: Market cap 1,324 KRWb, share price 26,850 KRW, 1-w performance 5.3%, 1-m performance 22.3%, 3-m performance 23.7%, ytd performance 12.8%
Donga Socio Holdings: Market cap 810 KRWb, share price 132,000 KRW, 1-w performance (1.1)%, 1-m performance (2.9)%, 3-m performance (3.7)%, ytd performance (15.7)%
Daewoong: Market cap 630 KRWb, share price 54,200 KRW, 1-w performance 5.2%, 1-m performance 29.2%, 3-m performance 18.9%, ytd performance 23.0%
JW Holdings: Market cap 502 KRWb, share price 8,180 KRW, 1-w performance (3.9)%, 1-m performance (12.8)%, 3-m performance (54.6)%, ytd performance (11.1)%
Chongkundang Holdings: Market cap 315 KRWb, share price 62,800 KRW, 1-w performance 0.2%, 1-m performance 6.8%, 3-m performance 2.8%, ytd performance (23.1)%

Pharmaceuticals

Hanmi Pharm: Market cap 3,550 KRWb, share price 318,000 KRW, 1-w performance 1.4%, 1-m performance 16.9%, 3-m performance (2.3)%, ytd performance (48.7)%
Yuhan: Market cap 2,640 KRWb, share price 223,000 KRW, 1-w performance 4.9%, 1-m performance 15.8%, 3-m performance 11.8%, ytd performance (24.7)%
Green Cross: Market cap 1,782 KRWb, share price 152,500 KRW, 1-w performance 3.7%, 1-m performance 8.2%, 3-m performance 10.1%, ytd performance (18.4)%
SK Chemicals (003520): Market cap 1,628 KRWb, share price 8,900 KRW, 1-w performance 19.0%, 1-m performance 14.0%, 3-m performance 3.1%, ytd performance (32.8)%
SK Chemicals (006120): Market cap 1,614 KRWb, share price 63,400 KRW, 1-w performance 1.2%, 1-m performance 3.3%, 3-m performance (5.4)%, ytd performance (6.9)%
Chong Kun Dang: Market cap 1,073 KRWb, share price 114,000 KRW, 1-w performance 14.7%, 1-m performance 19.0%, 3-m performance 9.1%, ytd performance 0.0%
Bukwang Pharm: Market cap 1,047 KRWb, share price 23,500 KRW, 1-w performance 0.6%, 1-m performance 2.2%, 3-m performance (11.0)%, ytd performance (24.2)%
Daewoong Pharm: Market cap 981 KRWb, share price 84,700 KRW, 1-w performance 0.5%, 1-m performance 20.5%, 3-m performance 24.9%, ytd performance (2.2)%
JW Pharmaceutical: Market cap 913 KRWb, share price 47,400 KRW, 1-w performance (0.7)%, 1-m performance 5.2%, 3-m performance (10.1)%, ytd performance (49.5)%
Donga ST: Market cap 819 KRWb, share price 97,000 KRW, 1-w performance 0.7%, 1-m performance 7.0%, 3-m performance (2.8)%, ytd performance (30.0)%

APIs

Kolon Life Science: Market cap 852 KRWb, share price 112,000 KRW, 1-w performance 0.5%, 1-m performance 4.2%, 3-m performance (15.0)%, ytd performance (4.6)%
ST Pharm: Market cap 787 KRWb, share price 42,550 KRW, 1-w performance 2.0%, 1-m performance 1.2%, 3-m performance (9.0)%, ytd performance (26.6)%
Kyongbo Pharmaceutical: Market cap 320 KRWb, share price 13,400 KRW, 1-w performance 0.4%, 1-m performance 3.3%, 3-m performance 2.5%, ytd performance (23.7)%
Daebongs: Market cap 136 KRWb, share price 12,300 KRW, 1-w performance (0.8)%, 1-m performance 3.4%, 3-m performance 9.3%, ytd performance (19.6)%
CKD Bio: Market cap 123 KRWb, share price 23,600 KRW, 1-w performance 0.6%, 1-m performance 11.1%, 3-m performance 8.5%, ytd performance (13.1)%
Estech Pharma: Market cap 123 KRWb, share price 10,800 KRW, 1-w performance 3.6%, 1-m performance 21.1%, 3-m performance 1.9%, ytd performance (37.9)%
Hwail Pharm: Market cap 111 KRWb, share price 7,710 KRW, 1-w performance (0.9)%, 1-m performance 4.8%, 3-m performance 2.5%, ytd performance (15.7)%

Industrial-use Enzymes

Amicogen: Market cap 371 KRWb, share price 40,750 KRW, 1-w performance 2.3%, 1-m performance 5.5%, 3-m performance (2.0)%, ytd performance (8.5)%
GenoFocus: Market cap 164 KRWb, share price 18,250 KRW, 1-w performance 1.2%, 1-m performance 3.8%, 3-m performance (11.2)%, ytd performance (21.2)%

Biosimilars

Celltrion: Market cap 1,2328 KRWb, share price 100,700 KRW, 1-w performance (0.2)%, 1-m performance 1.1%, 3-m performance (2.4)%, ytd performance (9.8)%
Samsung Biologics: Market cap 10,950 KRWb, share price 165,500 KRW, 1-w performance 3.1%, 1-m performance 6.8%, 3-m performance 9.6%, ytd performance (5.7)%
Binex: Market cap 485 KRWb, share price 15,500 KRW, 1-w performance 3.3%, 1-m performance 10.9%, 3-m performance (6.2)%, ytd performance (26.0)%
Alteogen: Market cap 185 KRWb, share price 29,400 KRW, 1-w performance 0.9%, 1-m performance 6.1%, 3-m performance 2.6%, ytd performance (10.2)%
ISU Abaxis: Market cap 159 KRWb, share price 8,040 KRW, 1-w performance 0.0%, 1-m performance 7.7%, 3-m performance (1.1)%, ytd performance (10.0)%

Stem Cell Therapy

Chabiotech: Market cap 653 KRWb, share price 12,900 KRW, 1-w performance 4.9%, 1-m performance 11.2%, 3-m performance (1.7)%, ytd performance (23.1)%
Medipost: Market cap 444 KRWb, share price 56,500 KRW, 1-w performance (0.5)%, 1-m performance 7.0%, 3-m performance (2.4)%, ytd performance (27.6)%
Pharmicell: Market cap 289 KRWb, share price 4,950 KRW, 1-w performance (2.6)%, 1-m performance 6.7%, 3-m performance (1.5)%, ytd performance (14.6)%
Tego Science: Market cap 181 KRWb, share price 23,450 KRW, 1-w performance (0.4)%, 1-m performance 1.7%, 3-m performance (8.1)%, ytd performance (11.0)%
Corestem: Market cap 173 KRWb, share price 11,000 KRW, 1-w performance (0.9)%, 1-m performance 1.9%, 3-m performance (4.1)%, ytd performance (15.7)%
Anterogen: Market cap 149 KRWb, share price 19,950 KRW, 1-w performance (0.6)%, 1-m performance 1.5%, 3-m performance (8.2)%, ytd performance (11.0)%
Kangstem Biotech: Market cap 141 KRWb, share price 9,900 KRW, 1-w performance (0.4)%, 1-m performance 1.3%, 3-m performance (2.5)%, ytd performance (23.1)%

Immune Cell Therapy

Green Cross Cell: Market cap 310 KRWb, share price 26,500 KRW, 1-w performance (0.6)%, 1-m performance 1.5%, 3-m performance (4.1)%, ytd performance (12.0)%
JW Shinyak: Market cap 292 KRWb, share price 7,470 KRW, 1-w performance (0.5)%, 1-m performance (1.0)%, 3-m performance (10.9)%, ytd performance (16.3)%
Green Cross Lab Cell: Market cap 280 KRWb, share price 26,500 KRW, 1-w performance (0.5)%, 1-m performance (1.0)%, 3-m performance (2.2)%, ytd performance (13.5)%

Molecular Diagnostics

Seegene: Market cap 881 KRWb, share price 33,600 KRW, 1-w performance (1.2)%, 1-m performance 0.2%, 3-m performance (1.0)%, ytd performance (11.0)%
Panagene: Market cap 202 KRWb, share price 6,800 KRW, 1-w performance 2.0%, 1-m performance 9.0%, 3-m performance (3.0)%, ytd performance (8.1)%
MG MED: Market cap 93 KRWb, share price 39,800 KRW, 1-w performance (0.4)%, 1-m performance 1.8%, 3-m performance (2.2)%, ytd performance (25.3)%
Bioneer: Market cap 87 KRWb, share price 5,400 KRW, 1-w performance (0.5)%, 1-m performance (1.0)%, 3-m performance (1.0)%, ytd performance (27.4)%

Medical Devices

Osstem Implant: Market cap 843 KRWb, share price 59,000 KRW, 1-w performance (5.9)%, 1-m performance 1.9%, 3-m performance (2.8)%, ytd performance (10.2)%
Viewworks: Market cap 639 KRWb, share price 63,900 KRW, 1-w performance (2.3)%, 1-m performance (8.7)%, 3-m performance 8.1%, ytd performance (11.4)%
Dio: Market cap 454 KRWb, share price 29,950 KRW, 1-w performance 0.5%, 1-m performance (11.4)%, 3-m performance (17.2)%, ytd performance (43.8)%
Value Added Technology: Market cap 418 KRWb, share price 28,150 KRW, 1-w performance (7.3)%, 1-m performance (17.2)%, 3-m performance (22.1)%, ytd performance (31.4)%
Interjo: Market cap 395 KRWb, share price 36,700 KRW, 1-w performance (0.7)%, 1-m performance (2.9)%, 3-m performance (13.1)%, ytd performance (27.4)%
Lutronic: Market cap 373 KRWb, share price 29,500 KRW, 1-w performance (5.3)%, 1-m performance (3.8)%, 3-m performance (13.2)%, ytd performance (27.0)%
InBody: Market cap 315 KRWb, share price 23,050 KRW, 1-w performance (1.7)%, 1-m performance (14.6)%, 3-m performance (40.1)%, ytd performance (14.6)%
Rayence: Market cap 313 KRWb, share price 18,850 KRW, 1-w performance (0.3)%, 1-m performance 7.7%, 3-m performance 9.9%, ytd performance (10.0)%
JVM: Market cap 293 KRWb, share price 46,250 KRW, 1-w performance 1.7%, 1-m performance (11.2)%, 3-m performance (8.5)%, ytd performance (26.6)%
Sewoon Medical: Market cap 173 KRWb, share price 3,960 KRW, 1-w performance (0.5)%, 1-m performance (8.9)%, 3-m performance (8.6)%, ytd performance (30.0)%
Huvitz: Market cap 165 KRWb, share price 13,900 KRW, 1-w performance (4.1)%, 1-m performance 9.5%, 3-m performance (12.0)%, ytd performance (16.8)%
Hans Biomed: Market cap 162 KRWb, share price 16,450 KRW, 1-w performance 1.5%, 1-m performance (10.6)%, 3-m performance (14.6)%, ytd performance (10.6)%
Coretec: Market cap 129 KRWb, share price 13,200 KRW, 1-w performance (3.2)%, 1-m performance (1.5)%, 3-m performance (6.7)%, ytd performance (14.6)%
Mediana: Market cap 118 KRWb, share price 13,650 KRW, 1-w performance (2.2)%, 1-m performance (13.1)%, 3-m performance (16.8)%, ytd performance (27.4)%
U&I Corporation: Market cap 113 KRWb, share price 14,750 KRW, 1-w performance (0.6)%, 1-m performance (1.9)%, 3-m performance (10.3)%, ytd performance (24.3)%
Meta Biomed: Market cap 95 KRWb, share price 4,330 KRW, 1-w performance (0.5)%, 1-m performance (1.9)%, 3-m performance (10.3)%, ytd performance (24.3)%
Hironic: Market cap 89 KRWb, share price 6,280 KRW, 1-w performance (3.2)%, 1-m performance (8.1)%, 3-m performance (1.3)%, ytd performance (42.1)%
CU Medical Systems: Market cap 48 KRWb, share price 3,300 KRW, 1-w performance (0.6)%, 1-m performance (0.8)%, 3-m performance (3.5)%, ytd performance (17.5)%

Telemedicine

Infiniti Healthcare: Market cap 167 KRWb, share price 6,860 KRW, 1-w performance (0.6)%, 1-m performance (0.4)%, 3-m performance 4.6%, ytd performance (23.0)%
UBCare: Market cap 143 KRWb, share price 3,550 KRW, 1-w performance 2.5%, 1-m performance 3.2%, 3-m performance (9.1)%, ytd performance (25.3)%
BIT Computer: Market cap 89 KRWb, share price 5,350 KRW, 1-w performance (1.5)%, 1-m performance (2.4)%, 3-m performance (34.0)%, ytd performance (2.4)%

Veterinary

Komi Pharm International (041960): Market cap 1,794 KRWb, share price 32,800 KRW, 1-w performance (0.8)%, 1-m performance 8.3%, 3-m performance (6.3)%, ytd performance (34.7)%
CTC Bio: Market cap 165 KRWb, share price 9,430 KRW, 1-w performance (3.0)%, 1-m performance 3.7%, 3-m performance 4.2%, ytd performance (20.8)%

Key Points

The global healthcare sector shows mixed performances, with the US and Europe indices leading in terms of ytd growth.
In Korea, the KRX Health Care index has the highest portion of the market cap, but some indices show negative performances.
Companies in the Pharmaceuticals and Medical devices sub-sectors have varying performances, with some experiencing significant declines and others showing positive growth.
Samsung Biologics is highlighted in several indices and shows a notable ytd performance.
The Nasdaq Biotechnology index in the US has a high forward P/E ratio, indicating higher valuation.
The MSCI Japan Healthcare Equipment and Services index shows a negative ytd performance, suggesting a decline in the sector.
Bioneer and MG MED have shown strong performances in the Molecular Diagnostics sub-sector.
InBody and Lutronic are notable in the Medical devices sub-sector, with positive ytd performance.